
Coalition releases Hawaii's first plan for water safety
Hawaii's first water safety plan has been released in an effort to reduce drownings in an island state with America's highest rate of visitor drownings and second highest for residents.
The new Hawai 'i Water Safety Coalition called its plan—'I Palekana Kakou ka Wai : Let Us Be Safe in the Water '—a road map to keep people safe 'on, in, and around the water.'
Hawaii becomes only the second state, after California, to embrace a challenge by the U.S. National Water Safety Action Plan for each state to write its own plan.
The coalition works under the umbrella of the Hawaiian Lifeguard Association, whose president, Kalani Vierra, issued a statement Thursday that also called drownings for local children ages 1 to 15 'the foremost cause of death.'
He called the situation 'heartbreaking.'
Fewer than 2 % of Hawaii second graders have the basic skills to avoid or save themselves from drowning, according to the coalition.
Don 't miss out on what 's happening !
Stay in touch with breaking news, as it happens, conveniently in your email inbox. It 's FREE !
Email 28141 Sign Up By clicking to sign up, you agree to Star-Advertiser 's and Google 's and. This form is protected by reCAPTCHA.
Among all resident drownings, Native Hawaiians and Pacific Islanders disproportionately have the highest death rate.
They make up about 27 % of Hawaii's population but represent 36 % of resident drowning deaths, according to the coalition.
'It is our collective responsibility, our kuleana, to protect our cherished waters and to raise awareness about the hidden dangers they may hold, ' Vierra said. 'Together, we can work to ensure a safer experience for everyone who enjoys the beauty of Hawaii.'
'We sincerely hope that the Hawai 'i Water Safety Action Plan will make a meaningful impact in reducing the tragic incidents of drowning and preventing aquatic injuries across our islands.'
Dr. Pat Morgan—a member of Hawaii's Child Death Review and medical director of the Kapi 'olani Child Advocacy and Protection Center at Kapi 'olani Medical Center for Women & Children—called childhood drownings 'preventable with constant adult supervision in and around the water, including at home, ' in a statement.
'Toddlers are especially at risk, as are children with other health conditions including autism. Our goal is to protect children from drowning in Hawai 'i.'
This legislative session, House Bill 1234 and Senate Bill 1223 would provide money for the Department of Education to create a standards-based Water Safety Education Pilot Program.
Rep. Jeanne Kapela (D, Volcano-Hawaiian Ocean View ) introduced HB 1234 and said in a statement, 'A water safety education program equips our keiki with the knowledge and skills they need to stay safe in and around the water, while minimizing risk in our communities.'
Sen. Glenn Wakai (D, Kalihi-Salt Lake-Pearl Harbor ) introduced SB 1223 and said in a statement, 'Our intention of introducing these bills is to safeguard our communities' health, prevent tragic accidents, and ensure that every family has peace of mind knowing their loved ones are safe in and around water.'
HB 1233 and SB 1222 would impose safety requirements for new 'retention and detention ponds ' such as requiring signs, fences and flotation devices.
HB 1233 and SB 1222 would prohibit counties from permitting new retention and detention ponds and require the state Health Department to inspect existing ones across the islands.
The retention and detention pond safety bills followed the death of Charlotte 'Sharkey ' Schaefers, who drowned Feb. 28, 2004, in a poorly maintained Navy housing retention detention pond that was designed to reduce the risk of homes getting flooded in a storm and had been swollen with stormwater.
Schaefers jumped into the pond to save a 3-year-old child who couldn't swim.
Her mother, Honolulu Star-Advertiser reporter Allison Schaefers, helped write the Hawai 'i Water Safety Plan and continues to advocate for passage of the bills this legislative session.
Schaefers and her family were awarded a $2 million settlement that represented the largest wrongful death settlement for a child in Hawaii at the time.
To view Hawaii's Water Safety Plan, visit.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
13 hours ago
- Yahoo
Starton Therapeutics Announces Phase 2a Clinical Trial for Continuous Low-Dose Lenalidomide (STAR-LLD) in Multiple Myeloma Open for Enrollment
Gabrail Cancer & Research Center activated and open to screen patients, with Nash Gabrail, MD as lead investigator Second site, Regional Medical Oncology Center, also activated Recent Phase 1b clinical study results concluded continuous low dose lenalidomide provides meaningful efficacy and improved tolerability with no grade >3 drug-related hematologic toxicity PARAMUS, N.J., June 12, 2025 (GLOBE NEWSWIRE) -- Starton Therapeutics Inc. ('Starton'), a clinical-stage biotechnology company transforming standard-of-care therapies with proprietary continuous delivery technologies, announced today Gabrail Cancer Center (GCC) in Canton, Ohio is now activated and open for enrolling patients in its Phase 2a clinical trial evaluating their continuous low-dose lenalidomide, STAR-LLD, for the treatment of multiple myeloma (MM). Dr. Nash Gabrail, medical oncologist and founder of the Center, is the study's lead investigator. Regional Medical Oncology Center, located in Wilson, NC, has also opened as the trial's second active clinical site. 'We are excited to announce this major milestone in our mission to bring breakthrough therapies to patients. This marks the next phase of development for our lead candidate, STAR-LLD, and represents a significant step forward for the entire team," stated Pedro Lichtinger, Chairman and Chief Executive Officer of Starton Therapeutics. 'We expect this study to expand on what we observed in our prior Phase 1b study, that continuous low-dose lenalidomide provides meaningful efficacy and improved tolerability,' added Dr. Jamie Oliver, Starton's Chief Medical Officer. 'The expanded cohort and dose escalation will help us determine the most effective dose, with the goal of maintaining acceptable safety and tolerability.' Starton, which recently presented the results of the Phase 1b portion of the study at the 2025 American Association for Cancer Research, will assess the safety and tolerability of low-dose lenalidomide in heavily treated MM patients. Continuous SC infusion (STAR-LLD) in combination with dexamethasone and a protease inhibitor (PI) will be compared to oral lenalidomide (Revlimid®) in combination with dexamethasone and a PI. The study will include at least 24 patients randomized to STAR-LLD and oral lenalidomide (Revlimid®). Up to 45 additional patients may be enrolled to identify the optimal dose for a future registrational study (based on ORR vs dose vs Grade 3-4 toxicity). Starton anticipates opening approximately 10 clinical sites. About STAR-LLD STAR-LLD is a continuous delivery lenalidomide (LLD) in development to expand and replace the standard-of-care for the most common blood cancers, multiple myeloma (MM), and chronic lymphocytic leukemia (CLL). A preclinical proof-of-concept study for subcutaneous STAR-LLD demonstrated that MM tumors caused by human myeloma cells grew 25-fold if untreated, five-fold when treated with daily lenalidomide, and shrank by 80% with STAR-LLD over a single 28-day cycle. The study also showed a 100% overall response rate (ORR) using continuous delivery LLD and 20% of animals in this cohort were tumor-free after 100 days, compared to a 0% ORR in animals treated with a 70% higher dose of lenalidomide given in single daily doses. In addition, a Phase 1b clinical study of six relapsed/refractory MM patients resulted in all patients that received STAR-LLD achieving an objective response (1 CR and 5 PRs); no patients experienced drug-related anemia, neutropenia, leukopenia, or thrombocytopenia greater than grade 2 in up to 12 cycles of therapy. The study concluded that continuous delivery of low dose lenalidomide (STAR-LLD) provides meaningful efficacy and improved tolerability with no grade > 2 drug-related hematologic toxicity. About Starton Therapeutics Starton Therapeutics is a clinical-stage biotechnology platform company focused on transforming standard-of-care therapies with proprietary continuous delivery technology, so people with cancer live better, for longer. Starton's proprietary technology is intended to increase the efficacy of approved drugs, make them more tolerable, and expand their potential use. To learn more, visit Forward Looking Statements All statements other than statements of historical facts included in this press release, including, without limitation, statements regarding our plans and objectives for future operations and expectations about current and future clinical trials, constitute 'forward-looking statements.' Forward-looking statements are subject to numerous conditions and known and unknown risks and uncertainties that could cause our actual results or events to differ materially from those included within the forward-looking statements. Readers are cautioned not to place undue reliance on these forward-looking statements, and except as required by law, Starton undertakes no obligation to disclose any revision to these forward-looking statements whether as a result of new information, future events, or otherwise. Investor Relations Contact Alex StarrManaging Director LifeSci Advisors astarr@ in to access your portfolio

Yahoo
2 days ago
- Yahoo
Queen's holds blessing ceremony for expanded emergency department
The Queen's Health Systems held a blessing ceremony on Tuesday to celebrate its newly expanded Emergency Department at its downtown campus. With the untying of maile lei, the department celebrated the newly renamed Uytengsu Family Emergency Department at The Queen's Medical Center in Honolulu. The department recently underwent renovations that expanded its size, more than doubling the number of its treatment rooms, and now offers dedicated facilities for state-of-the-art CT and X-ray services. 'Enhancing our Emergency Department with state-of-the-art expansion will be a game-changer and increase access to life-saving emergent services for all, ' said Jason Chang, Queen's president and CEO, in a news release. 'We remain committed to the mission of our founders, Queen Emma and King Kamehameha IV, to provide in perpetuity, quality health care services to improve the well-being of Native Hawaiians and all the people of Hawaii, and this new facility will help us achieve that for years to come.' The department was renamed in recognition of a rom Candice Uytengsu to support the expansion—the largest contribution to Queen's made by an individual. The first phase of the expansion is part of Queen's $1 billion, multi-campus master plan to better meet the current and future needs of patients. Queen's in May 2023 announced that construction would begin to upgrade the emergency department at its Punchbowl, or Manamana, campus. The Queen's Medical Center's Emergency Department—the state's only Level 1 trauma center—is considered the busiest in Hawaii, accommodating more than 62, 000 patients a year, including most of the state's most critically ill and vulnerable populations. It is also the state's only comprehensive stroke center, only organ transplant program, and the busiest STEMI (ST-elevation myocardial infarction ) center for the specific type of severe heart attack. It also cares for the greatest number of patients with behavioral health conditions, Queen's said. The new Emergency Department now offers 76 treatment rooms, up from 35 previously. It now has dedicated space for patients with behavioral health needs. It also has been designed to improve patient flow, allowing staff to separate patients with suspected or confirmed infectious disease from other patients, including those at higher risk. The department's mechanical systems have been upgraded to allow for negative air pressure needed for isolation rooms, along with enhanced air filtration to help prevent the spread of viruses. Additionally, the department now features The Wo Family Foundations Waiting Room, named in recognition of the Wo family's $1 million contribution. Last September, Queen's also held a groundbreaking ceremony for an emergency department expansion project at The Queen's Medical Center-West Oahu. Queen's-West has the second-busiest emergency department in the state. A new, three-story building and renovations are planned for the West Oahu campus, where demand for health care services is projected to increase by about 5 % each year. The West Oahu project is expected to be completed by summer 2027. The Uytengsu Family Emergency Department at Queen's Punchbowl campus is scheduled to officially open later this month.


Hamilton Spectator
2 days ago
- Hamilton Spectator
Ontario health units say measles vaccine registry missing ‘real-time data' on vaccination rates
Under fire for a growing measles outbreak linked to the death of a newborn last week, Health Minister Sylvia Jones is calling on people who are vaccine-resistant to get over it. But public health units in areas hit hard by the highly infectious disease said it's impossible to tell if that's happening because short-term data on measles shots is not immediately available in Ontario's public health system. 'This is a vaccine that has literally existed in the province of Ontario for five decades and when you have two shots you are almost 100 per cent protected. Think about that,' Jones said Tuesday. 'All of us are deeply concerned when we hear of individuals who, for any number of reasons, have chosen not to get vaccinated, some because of allergies, some because of religious and other reasons. It impacts us,' she added. 'This is an opportunity for all of us to understand that our actions have an impact on other people.' The infant who died was born prematurely and was infected in utero through a mother who had not been vaccinated. The newborn was also dealing with other serious health complications. There were renewed calls for Premier Doug Ford's government to step up efforts to fight measles and encourage shots, after Ontario's Chief Medical Officer, Dr. Kieran Moore on Thursday, revealed the fatality last Thursday. However, for now, health units can't tell if the infant's death has spurred more interest in shots, which cannot be taken during pregnancy. 'We do not have the ability to pull real-time data on vaccination uptake over a short window like this, unfortunately,' Southwestern Public Health, where the infant's death occurred, said in a statement to the Star. The health unit is based in St. Thomas to serve Elgin and Oxford counties. 'The majority of vaccination uptake remains at the primary care level, and without a provincial vaccine registry with real-time data, there is no system currently available that can provide this information,' the statement added. Chatham-Kent Public Health said it is also in the dark. 'At present, we do not have data available to assess any shifts in public sentiment regarding the measles vaccine,' said spokesperson Jacquie Cartwright. With the province acknowledging last week there have been six cases of congenital infection in the more than 2,000 cases reported in the province since last October, New Democrat MPP Robin Lennox (Hamilton Centre) said Tuesday the province needs a vaccine registry 'that would help us know who is most vulnerable and where to direct our resources.' The rising infection level shows the government's approach of telling people to see their family doctor or reach out to their local public health unit is not working, Lennox, a family physician, told the Star's Kristin Rushowy last week. 'Obviously, something has broken down, because the advice has been the same for many, many years and this is the only time where we've seen this kind of an outbreak in literally 30 years.' Public health units have held pop-up clinics near schools and churches since the outbreak began. Many of the current cases can be traced to a Mennonite wedding in New Brunswick last fall. Measles had been considered eradicated in Ontario for two decades.